Uncategorized

Full-Life Technologies raises $150M; Quince’s reboot with pulmonary drug

Published

on

Plus, news about Accro Bioscience, Hansa Biopharma, Shanghai Best-Link Bioscience and UCB.

Full-Life Technologies gets $150M: The radiotherapy company has raised $110 million in a Series D round and another $40 …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version